Evidence map›Paper›PMID 37175128›Full record

ArticleMolecules (Basel, Switzerland)2023

Chiral Indolizinium Salts Derived from 2-Pyridinecarbaldehyde-First Diastereoselective Syntheses of (-)-1-

Hisami Rodriguez-Matsui, David M Aparicio, María L Orea, Jorge R Juárez, Victor Gómez-Calvario, Dino Gnecco, Alan Carrasco-Carballo, Joel L Terán

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hisami Rodriguez-MatsuiCentro de Química, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Edif. IC9 Complejo de Ciencias, C.U., Puebla 72570, Mexico.
David M AparicioCentro de Química, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Edif. IC9 Complejo de Ciencias, C.U., Puebla 72570, Mexico.
María L OreaCentro de Química, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Edif. IC9 Complejo de Ciencias, C.U., Puebla 72570, Mexico.ORCID 0000-0002-2535-1013
Jorge R JuárezCentro de Química, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Edif. IC9 Complejo de Ciencias, C.U., Puebla 72570, Mexico.
Victor Gómez-CalvarioCentro de Química, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Edif. IC9 Complejo de Ciencias, C.U., Puebla 72570, Mexico.ORCID 0000-0002-5644-7114
Dino GneccoCentro de Química, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Edif. IC9 Complejo de Ciencias, C.U., Puebla 72570, Mexico.
Alan Carrasco-CarballoLaboratorio de Elucidación y Síntesis en Química Orgánica, Benemérita Universidad Autónoma de Puebla, C.U., Puebla 72570, Mexico.ORCID 0000-0003-1065-4211
Joel L TeránCentro de Química, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Edif. IC9 Complejo de Ciencias, C.U., Puebla 72570, Mexico.ORCID 0000-0002-4055-4353

Funding

Consejo Nacional de Ciencia y Tecnología 658640, A1-S-13280, 268178
6 · The paper itself

Abstract

The first diastereoselective synthesis of (-)-1-

Indexed as

(−)-1-epi-lentiginosinediastereoselective synthesisindolizinium saltstrans-epoxyamides

Identifiers

PMID37175128
PMCPMC10180032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.